Cargando…

Nanotechnology for Pediatric Retinoblastoma Therapy

Retinoblastoma is a rare, sometimes hereditary, pediatric cancer. In high-income countries this disease has a survival rate approaching 100%, while in low- and middle-income countries the prognosis is fatal for about 80% of cases. Depending on the stage of the disease, different therapeutic protocol...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Eleonora, Spallarossa, Andrea, Tasso, Bruno, Villa, Carla, Brullo, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504930/
https://www.ncbi.nlm.nih.gov/pubmed/36145308
http://dx.doi.org/10.3390/ph15091087